Identification of critical residues of influenza neuraminidase in viral particle release

Virology Journal

Volumn 8, Issue , 2011, Pages

  Tisoncik, Jennifer R ^a   Guo, Ying ^b   Cordero, Katie S ^a   Yu, Jia ^c   Wang, Jianwei ^d   Cao, Youjia ^c   Rong, Lijun ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b INSTITUTE OF MATERIA MEDICA   (China)

^c NANKAI UNIVERSITY   (China)

^d INSTITUTE OF PATHOGEN BIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

SIALIDASE; VIRUS GLYCOPROTEIN; MUTANT PROTEIN; NA PROTEIN, INFLUENZA A VIRUS; VIRUS PROTEIN;

AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME STRUCTURE; HUMAN; HUMAN CELL; INFLUENZA VIRUS A H5N1; NONHUMAN; SEQUENCE ALIGNMENT; VIRUS PARTICLE; VIRUS RELEASE; AMINO ACID SEQUENCE; CELL LINE; CHEMICAL STRUCTURE; CHEMISTRY; GENETICS; MISSENSE MUTATION; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY;

AVES;

AMINO ACID SEQUENCE; CELL LINE; DNA MUTATIONAL ANALYSIS; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTANT PROTEINS; MUTATION, MISSENSE; NEURAMINIDASE; SEQUENCE ALIGNMENT; VIRAL PROTEINS; VIRUS RELEASE;

EID: 78651333713     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-8-14     Document Type: Article

References (35)

1. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. K Subbarao A Klimov J Katz H Regnery W Lim, et al. Sci (Pubitemid 28063376)
2. Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates. YP Lin M Shaw V Gregory K Cameron W Lim, et al. Proc Natl Acad Sci USA 2000 97 9654 9658 10.1073/pnas.160270697 10920197 (Pubitemid 30650831)
3. Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. M Koopmans B Wilbrink M Conyn G Natrop H van der Nat, et al. Lancet 2004 363 587 593 10.1016/S0140-6736(04)15589-X 14987882 (Pubitemid 38264175)
4. Influenza: old and new threats. P Palese, Nat Med 2004 10 82 87 10.1038/nm1141 15577936
5. Influenza: lessons from past pandemics, warnings from current incidents. T Horimoto Y Kawaoka, Nat Rev Microbiol 2005 3 591 600 10.1038/nrmicro1208 16064053 (Pubitemid 41052146)
6. The genesis of a pandemic influenza virus. CJ Russell RG Webster, Cell 2005 123 368 371 10.1016/j.cell.2005.10.019 16269328 (Pubitemid 41546667)
7. Emerging and re-emerging infectious diseases: influenza as a prototype of the host-pathogen balancing act. AS Fauci, Cell 2006 124 665 670 10.1016/j.cell.2006.02.010 16497575 (Pubitemid 43261439)
8. H5N1 influenza - continuing evolution and spread. RG Webster EA Govorkova, N Engl J Med 2006 355 2174 2177 10.1056/NEJMp068205 17124014 (Pubitemid 44791158)
9. Cell surface CD4 inhibits HIV-1 particle release by interfering with Vpu activity. S Bour C Perrin K Strebel, J Biol Chem 1999 274 33800 33806 10.1074/jbc.274.47.33800 10559275 (Pubitemid 129511699)
10. HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. J Martin-Serrano T Zang PD Bieniasz, Nat Med 2001 7 1313 1319 10.1038/nm1201-1313 11726971 (Pubitemid 34007935)
11. Human and avian influenza viruses target different cell types in cultures of human airway epithelium. MN Matrosovich TY Matrosovich T Gray NA Roberts HD Klenk, Proc Natl Acad Sci USA 2004 101 4620 4624 10.1073/pnas.0308001101 15070767 (Pubitemid 38437460)
12. Influenza A virus neuraminidase limits viral superinfection. IC Huang W Li J Sui W Marasco H Choe, et al. J Virol 2008 82 4834 4843 10.1128/JVI.00079-08 18321971 (Pubitemid 351657045)
13. A novel mechanism for the acquisition of virulence by a human influenza A virus. H Goto Y Kawaoka, Proc Natl Acad Sci USA 1998 95 10224 10228 10.1073/pnas.95.17.10224 9707628 (Pubitemid 28415322)
14. Proteolytic cleavage by plasmin of the HA polypeptide of influenza virus: host cell activation of serum plasminogen. SG Lazarowitz AR Goldberg PW Choppin, Virology 1973 56 172 180 10.1016/0042-6822(73)90296-1 4795670
15. Proteolytic activation of the 1918 influenza virus hemagglutinin. C Chaipan D Kobasa S Bertram I Glowacka I Steffen, et al. J Virol 2009 83 3200 3211 10.1128/JVI.02205-08 19158246
16. Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus. LJ Mitnaul MN Matrosovich MR Castrucci AB Tuzikov NV Bovin, et al. J Virol 2000 74 6015 6020 10.1128/JVI.74.13.6015-6020.2000 10846083 (Pubitemid 30412971)
17. A release-competent influenza A virus mutant lacking the coding capacity for the neuraminidase active site. LV Gubareva MS Nedyalkova DV Novikov KG Murti E Hoffmann, et al. J Gen Virol 2002 83 2683 2692 12388803 (Pubitemid 35276967)
18. Accumulation of defective neuraminidase (NA) genes by influenza A viruses in the presence of NA inhibitors as a marker of reduced dependence on NA. MS Nedyalkova FG Hayden RG Webster LV Gubareva, J Infect Dis 2002 185 591 598 10.1086/339358 11865415 (Pubitemid 34171463)
19. Structure of the catalytic and antigenic sites in influenza virus neuraminidase. PM Colman JN Varghese WG Laver, Nature 1983 303 41 44 10.1038/303041a0 6188957 (Pubitemid 13125071)
20. Molecular determinants within the surface proteins involved in the pathogenicity of H5N1 influenza viruses in chickens. DJ Hulse RG Webster RJ Russell DR Perez, J Virol 2004 78 9954 9964 10.1128/JVI.78.18.9954-9964.2004 15331729 (Pubitemid 39187114)
21. Glycosylation of neuraminidase determines the neurovirulence of influenza A/WSN/33 virus. S Li J Schulman S Itamura P Palese, J Virol 1993 67 6667 6673 8411368 (Pubitemid 23309134)
22. Neuraminidase stalk length and additional glycosylation of the hemagglutinin influence the virulence of influenza H5N1 viruses for mice. Y Matsuoka DE Swayne C Thomas MA Rameix-Welti N Naffakh, et al. J Virol 2009 83 4704 4708 10.1128/JVI.01987-08 19225004
23. The special neuraminidase stalk-motif responsible for increased virulence and pathogenesis of H5N1 influenza A virus. H Zhou Z Yu Y Hu J Tu W Zou, et al. PLoS One 2009 4 6277 10.1371/journal.pone.0006277 19609439
24. Analysis of hemagglutinin-mediated entry tropism of H5N1 avian influenza. Y Guo E Rumschlag-Booms J Wang H Xiao J Yu, et al. Virol J 2009 6 39 10.1186/1743-422X-6-39 19341465
25. Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants. LV Gubareva RG Webster FG Hayden, Antimicrob Agents Chemother 2001 45 3403 3408 10.1128/AAC.45.12.3403-3408.2001 11709315 (Pubitemid 33107853)
26. Sequence and structure alignment of paramyxovirus hemagglutinin- neuraminidase with influenza virus neuraminidase. PM Colman PA Hoyne MC Lawrence, J Virol 1993 67 2972 2980 8497041 (Pubitemid 23143664)
27. Site-directed mutation of the active site of influenza neuraminidase and implications for the catalytic mechanism. MR Lentz RG Webster GM Air, Biochemistry 1987 26 5351 5358 10.1021/bi00391a020 3314986
28. The 2.2 A resolution crystal structure of influenza B neuraminidase and its complex with sialic acid. WP Burmeister RW Ruigrok S Cusack, Embo J 1992 11 49 56 1740114
29. Permissive secondary mutations enable the evolution of influenza oseltamivir resistance. JD Bloom LI Gong D Baltimore, Science 2010 328 1272 1275 10.1126/science.1187816 20522774
30. Highly pathogenic H5N1 influenza virus infection in migratory birds. J Liu H Xiao F Lei Q Zhu K Qin, et al. Science 2005 309 1206 10.1126/science. 1115273 16000410 (Pubitemid 41170907)
31. Influenza M2 envelope protein augments avian influenza hemagglutinin pseudotyping of lentiviral vectors. T McKay M Patel RJ Pickles LG Johnson JC Olsen, Gene Ther 2006 13 715 724 10.1038/sj.gt.3302715 16397505
32. Universal primer set for the full-length amplification of all influenza A viruses. E Hoffmann J Stech Y Guan RG Webster DR Perez, Arch Virol 2001 146 2275 2289 10.1007/s007050170002 11811679 (Pubitemid 34682391)
33. Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl- alpha-D-N-acetylneuraminate) substrate. M Potier L Mameli M Belisle L Dallaire SB Melancon, Anal Biochem 1979 94 287 296 10.1016/0003-2697(79)90362-2 464297 (Pubitemid 9173017)
34. The Protein Data Bank and the challenge of structural genomics. HM Berman TN Bhat PE Bourne Z Feng G Gilliland, et al. Nat Struct Biol 2000 7 Suppl 957 959 10.1038/80734 11103999
35. The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design. RJ Russell LF Haire DJ Stevens PJ Collins YP Lin, et al. Nature 2006 443 45 49 10.1038/nature05114 16915235 (Pubitemid 44344043)